Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.
about
Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Clinical Pharmacokinetics of S ...... Receptor-Neprilysin Inhibitor.
@en
Clinical Pharmacokinetics of Sacubitril/Valsartan
@nl
type
label
Clinical Pharmacokinetics of S ...... Receptor-Neprilysin Inhibitor.
@en
Clinical Pharmacokinetics of Sacubitril/Valsartan
@nl
prefLabel
Clinical Pharmacokinetics of S ...... Receptor-Neprilysin Inhibitor.
@en
Clinical Pharmacokinetics of Sacubitril/Valsartan
@nl
P2093
P2860
P1476
Clinical Pharmacokinetics of S ...... Receptor-Neprilysin Inhibitor.
@en
P2093
Gangadhar Sunkara
Parasar Pal
Sreedevi Boggarapu
Surya Ayalasomayajula
Thomas Langenickel
P2860
P2888
P356
10.1007/S40262-017-0543-3
P577
2017-04-17T00:00:00Z